Loading...

PR Information Data

155 개 8 페이지
번호 컨텐츠
50 AdipoLABs seeks to have an academic collaboration for cancer treatment with University of Cyberjaya, Malaysia HOT 2024-03-28   1720 (주)아디포랩스
49 ‘IVRA’ opens new possibilities for overcoming COVID-19 and cancer HOT 2024-03-14   1709 (주)아디포랩스
48 ‘REMISSION 1℃’ expected to be a ‘game changer’ in COVID-19 treatment HOT 2024-03-12   1708 (주)아디포랩스
47 AdipoLABs launches ‘high-frequency hyperthermia cancer treatment device’ in Malaysia HOT 2024-03-29   1708 (주)아디포랩스
46 AdipoLABs opens an office in Malaysia... Full-fledged entry into Southeast Asia HOT 2024-03-28   1701 (주)아디포랩스
45 ‘IVRA International Medical Conference’ held to share the latest knowledge on ‘cancer treatment-pain management’ HOT 2024-03-14   1698 (주)아디포랩스
44 Korea's largest '2022 IVRA International Medical Conference' to be held HOT 2024-03-14   1690 (주)아디포랩스
43 AdipoLABs and Cyberjaya University sign MOU for cancer treatment... “A great force in medical advancement” HOT 2024-03-28   1689 (주)아디포랩스
42 ‘K-Medical Device’ winning 1st place in Malaysian Oncology Society paper HOT 2024-03-29   1683 (주)아디포랩스
41 A new horizon in cancer treatment, the world is paying attention to hyperthermia cancer treatment device of ‘REMISSON 1℃’ HOT 2024-03-29   1677 (주)아디포랩스
40 AdipoLABs CEO Han Sung-ho was appointed as an advisory member of the Future Strategy Special Committee of the Constitutional Council. HOT 2024-03-14   1671 (주)아디포랩스
39 2022 IVRA International Medical Conference held successfully HOT 2024-03-14   1667 (주)아디포랩스
38 “COVID-19 treatment needs a major shift to hyperthermia therapy.” HOT 2024-03-12   1662 (주)아디포랩스
37 World's first joint collaboration to overcome COVID-19 treatment, IVRA is launched. HOT 2024-03-12   1642 (주)아디포랩스
36 Willing to do his best until the day humanity is free from disease HOT 2024-03-14   1633 (주)아디포랩스